| Use of alternative medicine for cancer and its impact on survival SB Johnson, HS Park, CP Gross, JB Yu JNCI: Journal of the National Cancer Institute 110 (1), 121-124, 2018 | 340 | 2018 |
| Complementary medicine, refusal of conventional cancer therapy, and survival among patients with curable cancers SB Johnson, HS Park, CP Gross, BY James JAMA oncology 4 (10), 1375-1381, 2018 | 329 | 2018 |
| Using ChatGPT to evaluate cancer myths and misconceptions: artificial intelligence and cancer information SB Johnson, AJ King, EL Warner, S Aneja, BH Kann, CL Bylund JNCI cancer spectrum 7 (2), pkad015, 2023 | 146 | 2023 |
| Cancer misinformation and harmful information on Facebook and other social media: a brief report SB Johnson, M Parsons, T Dorff, MS Moran, JH Ward, SA Cohen, ... JNCI: Journal of the National Cancer Institute 114 (7), 1036-1039, 2022 | 115 | 2022 |
| Radiosurgery for brain metastases: changing practice patterns and disparities in the United States BH Kann, HS Park, SB Johnson, VL Chiang, BY James Journal of the National Comprehensive Cancer Network 15 (12), 1494-1502, 2017 | 67 | 2017 |
| Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer DA Hamstra, MH Stenmark, T Ritter, D Litzenberg, W Jackson, S Johnson, ... International Journal of Radiation Oncology* Biology* Physics 85 (5), 1246-1253, 2013 | 60 | 2013 |
| MDM2 inhibition sensitizes prostate cancer cells to androgen ablation and radiotherapy in a p53-dependent manner FY Feng, Y Zhang, V Kothari, JR Evans, WC Jackson, W Chen, ... Neoplasia 18 (4), 213-222, 2016 | 57 | 2016 |
| Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer–specific death in patients receiving salvage radiation therapy following … W Jackson, DA Hamstra, S Johnson, J Zhou, B Foster, C Foster, D Li, ... Cancer 119 (18), 3287-3294, 2013 | 57 | 2013 |
| Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate cancer MH Stenmark, ASC Conlon, S Johnson, S Daignault, D Litzenberg, ... Radiotherapy and Oncology 110 (2), 291-297, 2014 | 56 | 2014 |
| A review of recent advances in thermophotovoltaics TJ Coutts, MW Wanlass, JS Ward, S Johnson Conference Record of the Twenty Fifth IEEE Photovoltaic Specialists …, 1996 | 47 | 1996 |
| The impact of numeracy on verbatim knowledge of the longitudinal risk for prostate cancer recurrence following radiation therapy DA Hamstra, SB Johnson, S Daignault, BJ Zikmund-Fisher, JMG Taylor, ... Medical Decision Making 35 (1), 27-36, 2015 | 38 | 2015 |
| Brachytherapy boost utilization and survival in unfavorable-risk prostate cancer SB Johnson, NH Lester-Coll, JR Kelly, BH Kann, BY James, SK Nath European Urology 72 (5), 738-744, 2017 | 35 | 2017 |
| Duration of androgen deprivation therapy influences outcomes for patients receiving radiation therapy following radical prostatectomy WC Jackson, MJ Schipper, SB Johnson, C Foster, D Li, HM Sandler, ... European urology 69 (1), 50-57, 2016 | 33 | 2016 |
| Overall survival is improved when DCIS accompanies invasive breast cancer AJ Kole, HS Park, SB Johnson, JR Kelly, MS Moran, AA Patel Scientific reports 9 (1), 9934, 2019 | 30 | 2019 |
| A prostate-specific antigen doubling time of< 6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post … WC Jackson, SB Johnson, D Li, C Foster, B Foster, Y Song, M Schipper, ... Radiation Oncology 8, 1-8, 2013 | 30 | 2013 |
| Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancer SB Johnson, PR Soulos, TD Shafman, CA Mantz, AP Dosoretz, R Ross, ... Radiotherapy and Oncology 121 (2), 294-298, 2016 | 25 | 2016 |
| Changes in length and complexity of clinical practice guidelines in oncology, 1996-2019 BH Kann, SB Johnson, HJWL Aerts, RH Mak, PL Nguyen JAMA Network Open 3 (3), e200841-e200841, 2020 | 24 | 2020 |
| What is the alternative? Responding strategically to cancer misinformation JS Peterson, B Swire-Thompson, SB Johnson Future oncology 16 (25), 1883-1888, 2020 | 19 | 2020 |
| The interval to biochemical failure is prognostic for metastasis, prostate cancer-specific mortality, and overall mortality after salvage radiation therapy for prostate cancer S Johnson, W Jackson, D Li, Y Song, C Foster, B Foster, J Zhou, ... International Journal of Radiation Oncology* Biology* Physics 86 (3), 554-561, 2013 | 18 | 2013 |
| Cohen SB Johnson, M Parsons, T Dorff, MS Moran, JH Ward P., Pine, DS, Klein, DF, Kasen, S., & Brook, JS, 2348-2351, 2000 | 18 | 2000 |
Daniel HamstraBaylor College of Medicine在 BCM.edu 的电子邮件经过验证
